Excess mortality in patients with asthma on long-acting beta2-agonists.

Abstract

A sthma ranks among the most common of chronic diseases in the Western world. Although modern therapy has improved patient care, asthma still affects 5–10% of the population and, according to the World Health Organization, claims the lives of some 12,000 patients per year in Western Europe [1]. b2-Agonists are potent bronchodilators and are the most widely… (More)

Topics

Cite this paper

@article{Hasford2006ExcessMI, title={Excess mortality in patients with asthma on long-acting beta2-agonists.}, author={J. Hasford and Johann Christian Virchow}, journal={The European respiratory journal}, year={2006}, volume={28 5}, pages={900-2} }